Credit Suisse’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$879K Hold
41,704
﹤0.01% 2336
2023
Q4
$749K Buy
41,704
+4,713
+13% +$84.6K ﹤0.01% 2518
2023
Q3
$609K Sell
36,991
-8,067
-18% -$133K ﹤0.01% 2568
2023
Q2
$901K Buy
45,058
+11,954
+36% +$239K ﹤0.01% 2436
2023
Q1
$626K Buy
33,104
+9
+0% +$170 ﹤0.01% 2602
2022
Q4
$751K Sell
33,095
-8,530
-20% -$193K ﹤0.01% 2525
2022
Q3
$1.1M Buy
41,625
+7,820
+23% +$207K ﹤0.01% 2241
2022
Q2
$835K Sell
33,805
-4,232
-11% -$105K ﹤0.01% 2495
2022
Q1
$1.26M Buy
38,037
+1,745
+5% +$57.9K ﹤0.01% 2381
2021
Q4
$1.19M Buy
36,292
+1,766
+5% +$57.8K ﹤0.01% 2472
2021
Q3
$1.45M Sell
34,526
-4,066
-11% -$171K ﹤0.01% 2350
2021
Q2
$1.5M Sell
38,592
-817
-2% -$31.8K ﹤0.01% 2362
2021
Q1
$1.35M Sell
39,409
-20,328
-34% -$694K ﹤0.01% 2390
2020
Q4
$2.71M Sell
59,737
-467,506
-89% -$21.2M ﹤0.01% 1942
2020
Q3
$14.5M Sell
527,243
-9,755
-2% -$268K 0.01% 851
2020
Q2
$19.8M Buy
536,998
+34,432
+7% +$1.27M 0.01% 744
2020
Q1
$16.3M Sell
502,566
-5,681
-1% -$184K 0.01% 732
2019
Q4
$20.8M Buy
508,247
+20,393
+4% +$836K 0.02% 746
2019
Q3
$17.4M Sell
487,854
-6,661
-1% -$237K 0.01% 754
2019
Q2
$25.4M Sell
494,515
-776
-0.2% -$39.9K 0.02% 604
2019
Q1
$28.4M Sell
495,291
-15,993
-3% -$917K 0.03% 518
2018
Q4
$21.4M Buy
511,284
+66,373
+15% +$2.78M 0.02% 620
2018
Q3
$33.6M Buy
444,911
+106,333
+31% +$8.03M 0.03% 500
2018
Q2
$24.3M Buy
338,578
+308,023
+1,008% +$22.1M 0.02% 616
2018
Q1
$912K Buy
30,555
+2,618
+9% +$78.1K ﹤0.01% 2636
2017
Q4
$930K Sell
27,937
-6,727
-19% -$224K ﹤0.01% 2587
2017
Q3
$1.14M Buy
34,664
+6,435
+23% +$212K ﹤0.01% 2555
2017
Q2
$557K Buy
28,229
+8,295
+42% +$164K ﹤0.01% 2711
2017
Q1
$384K Sell
19,934
-13,253
-40% -$255K ﹤0.01% 3068
2016
Q4
$616K Buy
+33,187
New +$616K ﹤0.01% 2982
2016
Q3
Sell
-11,390
Closed -$91K 3817
2016
Q2
$91K Buy
+11,390
New +$91K ﹤0.01% 3765